Skin Cancer

>

Latest News

FDA
FDA Approves Adjuvant Nivolumab for Stage IIB/C Melanoma

October 16th 2023

The FDA has approved adjuvant nivolumab to treat completely resected stage IIB/C melanoma.

Pembrolizumab Outperforms Ipilimumab in 7-Year Follow-Up of Patients With Advanced Melanoma
Pembrolizumab Outperforms Ipilimumab in 7-Year Follow-Up of Patients With Advanced Melanoma

August 23rd 2023

melanoma
ASCO Updates Systemic Therapy Guidelines for Melanoma

August 17th 2023

FDA Approves Hepzato Kit for Metastatic Uveal Melanoma With Liver Metastases
FDA Approves Hepzato Kit for Metastatic Uveal Melanoma With Liver Metastases

August 15th 2023

Pills © Grycaj
Patients Are Concerned About Developing an Opioid Addiction Following Mohs Microscopic Surgery

August 1st 2023

Video Interviews
Podcasts
The Vitals Podcast
the vitals
Oncology Nursing News
Key Advances in Cancer Survivorship Toxicity Management

More News

© 2023 MJH Life Sciences

All rights reserved.